Yu Fu

Ms. Yu Fu

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
YFYu Fu
Yu Fu
FCFang Chen
Fang Chen
LCLifen Cui
Lifen Cui
YZYue Zhao
Yue Zhao
HZHenan Zhang
Henan Zhang
JZJihong Zhang
Jihong Zhang
Clarifying changes in the immune microenvironment caused by vaccination is crucial for the development and application of vaccines. In this study, we analyzed seroconversion of antibodies, 12 key cytokines, and 34 lymphocyte subsets at three time points (D-1, D14, and D42) around vaccination and differences between two inactivated vaccines (Sinopharm and Sinovas) to understand the immune response induced by inactivated vaccines in the real world. The results showed that 62.5% and 75% of the participants achieved neutralizing antibody seroconversion on D14 and D42, respectively. After vaccination, IL-5 and IL-6 increased, and INF-γ decreased. IL6, IL-1B, INF-γ, IL-8, and IL-12p70 showed statistical significance in the comparison of different groups. In terms of lymphocyte subsets, CD3 +, CD56 +, CD3 + CD8 +, CD8 + CD71 +, and CD56 + CD71 + showed upward trend, while CD19 +, CD4 + CD8 +, CD8 + CD45RA +, CD4 + HLA-DR +, CD8 + HLA-DR +, and CD8 + CD38 + showed downward trend. Additionally, we found certain differences between the two vaccines in neutralizing antibodies, cytokines, and lymphocyte subsets. This research is a clinical observation on the immune response after vaccination through detecting various immune indicators, which showed that the inactivated vaccines induced both humoral immunity by producing neutralizing antibodies and cellular immunity. The cellular immunity induced by these two vaccines was a Th2-biased response, and it may also lead to a mild Th1-type response.

2 October 2020 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
JZJihong Zhang
Jihong Zhang
HZHenan Zhang
Henan Zhang
XWXiaohui Wang
Xiaohui Wang
YZYue Zhao
Yue Zhao
YFYu Fu
Yu Fu
XLXuan Liu
Xuan Liu

18 June 2025 in Oncogene
Verified
Journal Article
Closed access
PDF file
JLJianing Liu
Jianing Liu
JXJianan Xu
Jianan Xu
RSRongcan Sun
Rongcan Sun
XWXiaohui Wang
Xiaohui Wang
FCFang Chen
Fang Chen
SFShuang Fu
Shuang Fu

1 January 2025 in Human Mutation
Verified
Journal Article
Open access
YSYiyang Shen
Yiyang Shen
SFShuang Fu
Shuang Fu
XLXuan Liu
Xuan Liu
JLJianing Liu
Jianing Liu
YFYu Fu
Yu Fu
JZJihong Zhang
Jihong Zhang
A great part of studies on the correlation between gene mutations and prognosis in acute myeloid leukemia (AML) patients are based on Western populations. To profile the genomic landscape of AML patients in Northeast China, we retrospectively analyzed the clinical data of 377 newly diagnosed AML patients in Shengjing Hospital of China Medical University from 2016 to 2022 and compared them with data from other populations with different genetic backgrounds. The mutation status of NPM1, FLT3-ITD, FLT3-TKD, CEBPA (CCAT enhancer binding protein alpha), ASXL1, TET2, KIT, DNMT3A (DNA methyltransferase 3A), IDH1, IDH2, EZH2 (enhancer of zeste 2), RUNX1, TP53, NRAS, and GATA2 was acquired by next‐generation sequencing (NGS) technology; meanwhile, the clinical data of the patients were collected. The Cox regression model was used to analyze factors affecting patient survival and the impact of CEBPA and DNMT3A mutation on prognosis, and the results were different from those in other populations. Seventy‐seven of 377 patients (20.4%) were detected with CEBPA mutations, which was higher than the 2%–6% in the Caucasian population. In the CEBPAdm patients who did not receive bone marrow transplantation, the prognosis of male patients (n = 18) was significantly better than that of female patients (n = 21) (p = 0.0242). Sixty‐three of 377 patients (16.7%) carried the DNMT3A mutation, which was lower than the mutation frequency of 20.9% in the German–Austrian population, and the prognosis of these patients was significantly poorer (p = 0.0052). In addition, the prognostic evaluation value of the DNMT3A mutation in AML patients was not affected regardless of the presence of the NPM1 and FLT3-ITD comutation (p > 0.05), nor the mutation site of DNMT3A. In conclusion, for the Northeastern Chinese population, the prognosis of male patients with CEBPAdm was more favorable than that of female patients, and the DNMT3A mutation serves as an independent predictor of poor prognosis in AML. These results highlighted the central role of genetic background in precision medicine strategies and further emphasized the importance of the clinical characteristics of AML gene mutations in the Chinese population.

1 October 2016
Verified
Journal Article
Closed access
ZCZuo-Fei Chi
Zuo-Fei Chi
WYWei Yang
Wei Yang
QHQiu-Ying He
Qiu-Ying He
SFShuang Fu
Shuang Fu
YFYu Fu
Yu Fu